Ecosystem Synergy for Efficient Drug Discovery

Devinebio is using the Devine Process to building an ecosystem for discovery and development of drugs in Rare Disease. Three functions of Devinebio are:

  • Biotech Incubator - We create companies to mature a drug asset towards an exit with Pharma.

  • Marketplace - We select experts to provide services that help mature drug assets to high value.

  • Platform - We develop innovative iPSC platforms for use in drug discovery and development.

The synergy between these complementary functions helps grow the ecosystem.

Read on to get more details on each of these functions:

Biotech Incubator

Devinebio creates and incubates drugs discovery biotechs that we call Special Purpose Exit Companies (or SPECs). Each SPECs sole purpose is to grow a set of drug discovery assets to sufficient value that they become attractive acquisition targets for big Pharma. To grow the value in these assets, we focus on 5 area of drug development:

  • Population - get that contact list of patients to a high number (>1000)

  • Biomarker - get the assays tests developed that find drugs and the surrogate endpoints for clinical trial efficacy.

  • Drugs - find the hits and groom them for the best leads

  • IP - file quickly on discoveries before public disclosure

  • Regulatory - engage with FDA and get assets moving towards IND.

Marketplace of Experts

Devinebio seeks out the professionals who can help a SPEC mature the value of its assets.  We vet them for their fit into our Collective of Experts. These experts can deploy for a SPEC on a Just-in-Time basis and perform Fee-for-Service on a drug development aspect, only at the time when it is needed.  This fractional effort at the appropriate time keeps costs of drug development well contained.

Platform Technology

Devinebio creates innovative platforms for efficient discovery and development of therapeutics. We focus on iPSC-derived tissue systems because of their high translational capacity from drug screen to clinic effectiveness.  However, we will also utilized other model systems (mice, zebrafish, worms and fly), when the biology is known to be sufficiently conserved. Our model systems are used by the SPECs to quickly and accurately find therapeutics for a rare disease.

In summary we have created Devine Process - a drug discovery and development ecosystem for rapid generation of therapeutic options in Rare Disease.

Patient Advocacy Groups, Clinicians, Researchers, Drug Hunters and Drug Development Experts come together to collaborate and expedite new drug therapies for their introduction into the clinic.

Get in Touch

Are you interested in participating with us in drug development for Rare?

Reach out and use the form,

or send email to: info@devinebio.com